reported a positive association between serum PON3 and β-2-microglobulin, CCL2 and high-sensitivity C-reactive protein in CAD patients but insignificant differences in PON3 gene promoter polymorphisms and their haplotypes between CAD patients and controls, indicating that these associations were not genetically determined. This evidence concerns the gene PON3 and coronary artery disorder.